Ennis, Inc.: Form 10-Q for the period ended Nov 30, 2024
Filed with the SEC on Jan 7, 2025 and accepted by EDGAR at Jan 7, 2025, 14:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-11-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-09-01 to 2024-11-30 | $99.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-03-01 to 2024-11-30 | $301.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-09-01 to 2024-11-30 | $70.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-03-01 to 2024-11-30 | $212.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-09-01 to 2024-11-30 | $29.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-03-01 to 2024-11-30 | $89.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-09-01 to 2024-11-30 | $16.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-03-01 to 2024-11-30 | $50.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-09-01 to 2024-11-30 | $13.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-03-01 to 2024-11-30 | $40.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-09-01 to 2024-11-30 | $3.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-03-01 to 2024-11-30 | $11.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-09-01 to 2024-11-30 | $10.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-03-01 to 2024-11-30 | $31.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-09-01 to 2024-11-30 | $0.39 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-03-01 to 2024-11-30 | $1.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-09-01 to 2024-11-30 | $0.39 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-03-01 to 2024-11-30 | $1.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-09-01 to 2024-11-30 | 26,088,957 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-03-01 to 2024-11-30 | 26,192,008 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-03-01 to 2024-11-30 | $53.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-03-01 to 2024-11-30 | $4.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2024-09-01 to 2024-11-30 | $72.3m | us-gaap:PaymentsOfDividends |
| Dividends paid | 9 months2024-03-01 to 2024-11-30 | $85.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2024-03-01 to 2024-11-30 | $1.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-11-30 | $55.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-11-30 | $152.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-11-30 | $346.1m | us-gaap:Assets |
| Current liabilities | At period end2024-11-30 | $32.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-11-30 | $48.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-11-30 | $297.7m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-12-01 | 26,012,603 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-25-002567. Last ingested by Listed: Oct 24, 2026, 14:52 ET. Listed shows no prices and gives no investment advice.